The complex nature of today’s global supply chain has created increased challenges for the FDA and its regulatory and law enforcement partners around the world. FDA’s efforts to secure the global supply chain include minimizing risks along the supply chain, from the source of a product’s ingredients through the product’s manufacture, storage, transit, sale, and distribution. When international and U.S. based criminal organizations compromise the integrity of the supply chain, consumers are put at risk of serious illnesses and even death. The discussion will focus on FDA’s Office of Criminal Investigations’ (FDA-OCI) efforts to keep illegal products out of the supply chain and how FDA-OCI is working collaboratively with our foreign counterparts to address these challenges globally. SUPPLY CHAIN SECURITY Programme correct as of 8 April 2015